This website provides educational information about medicines and active ingredients. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Pharmacists

Myfortic 360 mg Gastro-Resistant Tablets: SmPC Summary

Quick summary: Myfortic 360 mg gastro-resistant tablets contain mycophenolic acid and are used in transplant medicine as part of immunosuppressive treatment, mainly to help prevent kidney transplant rejection. This page gives a practical SmPC-style...

Educational content Use this article as a starting point for understanding the topic.
Check with a professional Ask a doctor or pharmacist before changing any medicine.
Safety first Side effects, interactions and risks depend on each person.
Medical disclaimer

This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.

Quick summary: Myfortic 360 mg gastro-resistant tablets contain mycophenolic acid and are used in transplant medicine as part of immunosuppressive treatment, mainly to help prevent kidney transplant rejection.

This page gives a practical SmPC-style overview of what the medicine is for, how it is usually taken, common side effects, and what to check in the official leaflet or with a healthcare professional.

Medical disclaimer: This article is for general information only and does not replace the Summary of Product Characteristics, Patient Information Leaflet, or advice from a doctor or pharmacist. Do not use this page to diagnose a condition or to change prescribed treatment.

What are Myfortic 360 mg gastro-resistant tablets?

Myfortic 360 mg gastro-resistant tablets contain mycophenolic acid, an immunosuppressant medicine. The gastro-resistant tablet is designed to release the medicine in the gastrointestinal tract.

Myfortic is used in transplant medicine and is part of a broader immunosuppressive regimen. It is produced by Novartis.

What is Myfortic 360 mg used for?

Myfortic 360 mg is primarily used to help prevent acute rejection in kidney transplant recipients. It is usually used alongside other medicines as part of a transplant treatment plan.

  • Prevention of kidney transplant rejection
  • Use as part of combination immunosuppressive therapy

Any other use should be guided by a qualified prescriber and supported by official product information.

How is Myfortic 360 mg usually taken?

The current content states that the usual regimen is 360 mg twice daily, which equals 720 mg per day. Tablets are taken with water.

Patients should follow the prescribed schedule exactly and check the Patient Information Leaflet for practical instructions. If anything is unclear, a pharmacist or transplant team should confirm how the medicine should be taken.

Important administration points

  • Take only as prescribed.
  • Use the official leaflet for full instructions.
  • Do not make dose changes without medical advice.

What are the side effects of Myfortic 360 mg?

Like other immunosuppressants, Myfortic can cause side effects. The current content highlights gastrointestinal effects and a higher risk of infections.

  • Diarrhoea
  • Nausea
  • Vomiting
  • Increased susceptibility to infections
  • Blood disorders such as anaemia or leukopenia
  • Potential risk of malignancies associated with immunosuppression

Any new, severe, or persistent symptom should be reviewed by a healthcare professional.

How does Myfortic compare with CellCept?

Myfortic and CellCept are both mycophenolate medicines, but they are not the same formulation.

  • Myfortic is the gastro-resistant form of mycophenolic acid.
  • CellCept contains mycophenolate mofetil and is available as a tablet or oral suspension.

The current content notes that Myfortic may be associated with fewer gastrointestinal side effects for some patients, while both medicines are used to help prevent transplant rejection.

What alternatives are mentioned?

The original content lists several medicines that may be used in immunosuppressive therapy, depending on the clinical situation.

  • CellCept (mycophenolate mofetil)
  • Azathioprine
  • Corticosteroids such as prednisone
  • Calcineurin inhibitors such as tacrolimus and cyclosporine

Choice of treatment depends on the transplant plan and the prescriber’s judgement.

How much does Myfortic 360 mg cost?

Price can vary depending on the pharmacy, location, and insurance coverage. The current content gives an approximate retail range of $500 to $1,000 per month.

For the most accurate pricing, patients should check with a pharmacy or their healthcare team and review any available assistance options.

What ingredients are in Myfortic 360 mg?

The active ingredient is mycophenolic acid. The tablet also contains inactive ingredients that support the formulation and gastro-resistant design.

For the full ingredient list, the official Patient Information Leaflet should be checked.

Myfortic 360 mg at a glance

Topic Summary
Active ingredient Mycophenolic acid
Main use Prevention of kidney transplant rejection
Formulation Gastro-resistant tablets
Commonly noted side effects Diarrhoea, nausea, vomiting
Key safety issue Increased risk of infection and other immunosuppression-related risks

FAQs about Myfortic 360 mg

▸ What is Myfortic 360 mg used for?

It is primarily used to help prevent acute rejection in kidney transplant recipients as part of immunosuppressive therapy.

▸ What is the active ingredient in Myfortic?

The active ingredient is mycophenolic acid.

▸ How is Myfortic different from CellCept?

Myfortic is the gastro-resistant form of mycophenolic acid, while CellCept contains mycophenolate mofetil. Both are used in transplant medicine, but they are different formulations.

▸ What side effects are mentioned in the original content?

The original content mentions diarrhoea, nausea, vomiting, increased infection risk, blood disorders such as anaemia or leukopenia, and a potential malignancy risk linked to immunosuppression.

▸ Where can I check the full official information?

Check the Summary of Product Characteristics and the Patient Information Leaflet, or ask a pharmacist or transplant specialist for guidance.

Safety reminder: Because Myfortic is an immunosuppressant, any concerns about infection, blood problems, or unexpected symptoms should be discussed with a healthcare professional promptly. Always rely on the official product leaflet and the prescribing team for medicine-specific instructions.

Editorial note Active Ingredients Online Editorial Team This article is prepared as educational medicine information for general readers. It is written to support understanding of active ingredients, medicine uses, possible side effects, precautions and safety-related questions.
Published: November 29, 2024 Updated: August 17, 2026 Educational content

Medical disclaimer

This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.

Sources and verification

The following sources or official references are listed to support verification of the medicine information discussed in this article.

Final note

Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.

Ask a Doctor Online medical questions